Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High-Dose Chemotherapy for Recurrent Ovarian Germ Cell Tumors

2 Dec 2014

Abstract excerpt

Thirteen patients with recurrent malignant ovarian germ cell tumors (MOGCT) were treated with salvage highdose chemotherapy (HDCT) from 1990 to 2013. All patients had experienced disease progression after standard cisplatin combination therapy. Patients treated with HDCT as initial salvage treatment for platinum sensitive disease (progression-free interval 4 weeks) received one cycle of vinblastine, ifosfamide,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ovarian cancer diagnosis and treatment
Share to Testicular diseases and treatments
Share to Urologic and reproductive health conditions

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25452440
DOI: 10.1200/jco.2014.59.4325

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

High-Dose Chemotherapy for Recurrent Ovarian Germ Cell TumorsPMID 25452440Read ↗

Salvage high-dose chemotherapy for children with extragonadal germ-cell tumoursSemantic proximity Read ↗

Cytoreductive Surgery (CRS) Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Platinum-Sensitive Recurrence Epithelial Ovarian Cancer With HRR Mutation: A Phase III Randomized Clinical Trial.Semantic proximity Read ↗

Immunotherapy in Testicular Germ Cell TumorsSemantic proximity Read ↗

A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancerSemantic proximity Read ↗

Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancerSemantic proximity Read ↗

Updates in the Management of Malignant Ovarian Germ Cell TumorsSemantic proximity Read ↗

Malignant ovarian and testicular germ cell tumors: Common characteristics but different prognosesSemantic proximity Read ↗

Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: An overviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.